Indacaterol
CAS 312753-06-3
Overview
Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease
Anant Labs manufacture and furnish high quality Indacaterol impurities for global markets. Our Indacaterol EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS312753-06-3
Mol. FormulaC24H28N2O3
Mol. Weight392.499 g/mol
IUPAC5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one
SMILESCCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC
InChIInChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1
InChI KeyQZZUEBNBZAPZLX-QFIPXVFZSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Indacaterol312753-06-3OnbrezQAB-149QAB149QAB 149Indacterol8OR09251MQ5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-oneQABI49
